A Single-arm, Multi-center Phase II Clinical Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer Who Had Recurrence of the Pelvic Wall After Surgery ± Abdominal Aortic Lymph Node Metastasis
Latest Information Update: 06 Jul 2023
At a glance
- Drugs Camrelizumab (Primary) ; Carboplatin; Cisplatin
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 27 Jul 2021 New trial record